Key result
Adoptively transferred heart-specific CD4+ T cells rapidly acquired an induced regulatory phenotype in the infarcted myocardium and blunted local inflammation.
Why the study?
The differentiation trajectories and in situ activity of heart-specific CD4+ T cells activated in the setting of myocardial infarction remained poorly understood.
Does adoptive transfer of pre-differentiated myosin-specific CD4+ T cells improve post-myocardial infarction inflammation in murine models?
Does adoptive transfer of pre-differentiated myosin-specific CD4+ T cells improve post-myocardial infarction inflammation in murine models?
Answers are grounded in this paper and cite their sources.
The myocardial milieu provides a suitable environment for induced regulatory T cell differentiation, revealing novel mechanisms by which the healing myocardium shapes local immunological processes.
Background Myocardial infarction (MI) is a sterile inflammatory condition associated with tissue injury that results in the activation of T helper cell targeting cardiac antigens. However, the differentiation trajectories and in situ activity of heart-specific CD4 + T cells activated in the MI context remain poorly understood. Methods Herein, we combined T-cell receptor transgenic models targeting myocardial protein, single-cell transcriptomics, and functional phenotyping to elucidate how the myosin-specific CD4 + T cells (TCR-M) differentiate in the murine infarcted myocardium and ultimately influence tissue repair. Furthermore, we adoptively transferred heart-specific T-cells that were pre-differentiated in vitro towards pro-inflammatory versus regulatory phenotypic states to dissect how they differentially regulate post-myocardial infarction (MI) inflammation. Results Flow cytometry and single-cell transcriptomics findings reveled that transferred TCR-M cells rapidly acquired an induced regulatory phenotype (iTreg) in the infarcted myocardium and blunt local inflammation. Myocardial TCR-M cells differentiated into two main lineages enriched with cell activation and pro-fibrotic transcripts (e.g. Tgfb1 ) or with suppressor immune checkpoints (e.g. Pdcd1 ), which we also found in human myocardial tissue. These cells produced high levels of latency-associated peptide (LAP) and inhibited interleukine-17 (IL-17) responses. Notably, TCR-M cells that were pre-differentiated in vitro towards a regulatory phenotype maintained a stable in vivo FOXP3 expression and anti-inflammatory activity when adoptively transferred prior to MI induction. In contrast, TCR-M cells that were pre-differentiated in vitro towards a pro-inflammatory T H 17 phenotype were partially converted towards a regulatory phenotype in the injured myocardium and blunted myocardial inflammation. Conclusions These findings reveal that the myocardial milieu provides a suitable environment for iTreg differentiation and reveals novels mechanisms by which the healing myocardium shapes local immunological processes.
No takes yet. Share an insight, caveat, or question.
Delgobo et al. (2022) studied Myocardial infarction. Adoptive transfer of heart-specific CD4+ T cells (TCR-M) vs. Sham-operated or no-transfer infarcted controls was evaluated on T-cell differentiation and myocardial inflammation. Adoptively transferred heart-specific CD4+ T cells rapidly acquired an induced regulatory phenotype in the infarcted myocardium and blunted local inflammation.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: